Hepatitis B Vaccine
Dynavax's Heplisav hepatitis B vaccine shows Phase II 100% seroprotection regardless of schedule
Published in Hepatitis Weekly, January 1st, 2007
The primary endpoint is comparative seroprotection after the second dose. The data was reported in a poster at the Canadian Immunization Conference in Winnipeg, Manitoba, Canada by Dr. Scott A. Halperin, professor of pediatrics and microbiology and immunology at Dalhousie University and head of pediatric infectious disease at the Halifax-based IWK Health Center.
The data show that 100% seroprotection is achieved whether the second dose is administered one or two months...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2007-01-01)
More Articles from Hepatitis Weekly
- Hepatitis B Virus
Research from California Pacific Medical Center has provided new information about hepatitis b virus - Hepatitis B Virus
Research from Korea Research Institute of Bioscience and Biotechnology provides new data on hepatitis b virus - Hepatitis B Virus
Studies from Pennsylvania State University have provided new information about hepatitis b virus - Hepatitis B Virus Cell Biology
New hepatitis b virus cell biology research reported from Ajou University, Department of Microbiology - Hepatitis B Virus Cell Biology
Research from Korea Research Institute of Bioscience and Biotechnology yields new findings on hepatitis b virus cell biology - Hepatitis B Virus Gene Therapy
Studies from Zhejiang University, Institute of Infectious Disease reveal new findings on hepatitis b virus gene therapy - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
